XML 59 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
OPERATING ACTIVITIES    
Net income including non-controlling interests $ 15,743 $ 12,983
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation and amortization 2,825 2,730
Provision for doubtful accounts 2,004 2,282
Equity-based awards compensation expense 1,593 1,370
Loss on sale of business and sale or abandonment of assets, net 34 84
Excess tax benefit from exercise of stock options (215) 0
Deferred income tax 2,422 (796)
Other 0 33
Changes in operating assets and liabilities:    
Increase in patient accounts receivable (4,442) (2,542)
(Increase) decrease in accounts receivable - other (80) 4
Decrease in other assets 1,540 3,867
(Decrease) increase in accounts payable and accrued expenses (774) 682
Increase in other liabilities 404 19
Net cash provided by operating activities 21,054 20,716
INVESTING ACTIVITIES    
Purchase of fixed assets (2,132) (2,394)
Purchase of businesses, net of cash acquired (10,750) (9,998)
Acquisitions of non-controlling interests (4,945) (1,064)
Proceeds on sale of business and fixed assets, net 38 15
Net cash used in investing activities (17,789) (13,441)
FINANCING ACTIVITIES    
Distributions to non-controlling interests (4,982) (4,410)
Cash dividends to shareholders (2,932) (2,418)
Proceeds from revolving line of credit 77,000 62,550
Payments on revolving line of credit (72,000) (64,200)
Payment of notes payable (575) (234)
Excess tax benefit from stock options exercised 215 33
Other 45 20
Net cash used in financing activities (3,229) (8,659)
Net increase in cash 36 (1,384)
Cash - beginning of period 12,898 11,671
Cash - end of period 12,934 10,287
Cash paid during the period for:    
Income taxes 3,235 1,999
Interest 657 237
Non-cash investing and financing transactions during the period:    
Purchase of business - seller financing portion 400 800
Revaluation of redeemable non-controlling interests $ 1,841 $ 0